216 related articles for article (PubMed ID: 9051241)
21. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
22. Combined CD34 positive plus CD2 negative selection for effective T-cell depletion as GvHD-prophylaxis in HLA-nonidentical blood progenitor cell transplantation.
Wiesneth M; Schreiner T; Friedrich W; Müller S; Maccari B; Erne E; Bischof C; Kubanek B
Transfus Sci; 1996 Dec; 17(4):629-35. PubMed ID: 10168563
[TBL] [Abstract][Full Text] [Related]
23. Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries.
Clarke E; Potter MN; Hale G; Waldmann H; Lankester A; Cornish JM; Steward CG; Marks DI; Oakhill A; Pamphilon DH
Bone Marrow Transplant; 1998 Jul; 22(2):117-24. PubMed ID: 9707017
[TBL] [Abstract][Full Text] [Related]
24. Treatment of donor T cell-mediated hematopoietic suppression after haploidentical bone marrow transplantation by T cell modulation in a patient with severe combined immunodeficiency.
Dilloo D; Hanenberg H; Schneider EM; Hauch M; Nürnberger W; Zimmer BM; Vöhringer R; Wernet P; Göbel U; Burdach SE
Bone Marrow Transplant; 1992 Jan; 9(1):57-62. PubMed ID: 1531938
[TBL] [Abstract][Full Text] [Related]
25. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
[TBL] [Abstract][Full Text] [Related]
26. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
[TBL] [Abstract][Full Text] [Related]
27. Successful transplantation of haploidentical CD34+ selected bone marrow cells for an infantile case of severe combined immunodeficiency with aspergillus pneumonia.
Yoshihara T; Morimoto A; Nakauchi S; Fujii N; Tsunamoto K; Misawa A; Hibi S; Imashuku S
Pediatr Hematol Oncol; 2002 Sep; 19(6):439-43. PubMed ID: 12186368
[TBL] [Abstract][Full Text] [Related]
28. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel PG; Greil J; Stachel D; Herzog RJ; Niethammer D
Bone Marrow Transplant; 2001 Apr; 27(8):777-83. PubMed ID: 11477433
[TBL] [Abstract][Full Text] [Related]
29. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
[TBL] [Abstract][Full Text] [Related]
30. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
Palmer K; Green TD; Roberts JL; Sajaroff E; Cooney M; Parrott R; Chen DF; Reinsmoen NL; Buckley RH
J Allergy Clin Immunol; 2007 Aug; 120(2):423-8. PubMed ID: 17481714
[TBL] [Abstract][Full Text] [Related]
31. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
32. In utero hematopoietic stem cell transplants for inherited diseases.
Cowan MJ; Golbus M
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):35-42. PubMed ID: 7906103
[TBL] [Abstract][Full Text] [Related]
33. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
[TBL] [Abstract][Full Text] [Related]
34. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
35. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
[TBL] [Abstract][Full Text] [Related]
36. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ
Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691
[TBL] [Abstract][Full Text] [Related]
37. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
[TBL] [Abstract][Full Text] [Related]
38. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
39. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
[TBL] [Abstract][Full Text] [Related]
40. Antibody and pre- plus post-transplant prednisone treatments support T cell-depleted stem cell engraftment without drug-induced morbidity.
D'Costa S; Hurwitz JL
Bone Marrow Transplant; 2002 Apr; 29(7):553-6. PubMed ID: 11979302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
